Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 3 institutions in 3 countries.
Narges CheshmazarBiotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran.ORCID 0000-0002-9998-8121
Maryam Hamzeh-MivehroudBiotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran.ORCID 0000-0002-1257-0102
Salar HemmatiDrug applied research Center, Tabriz University of Medical Sciences, Tabriz, 5165665811, Iran.ORCID 0000-0002-3431-8629
Hoda AbolhasaniCellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.ORCID 0000-0001-9174-5304
Fatemeh HeidariCellular & Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.ORCID 0000-0003-4751-8870
Hojjatollah Nozad CharoudehAnatomical Sciences Department, Faculty of Medicine, Tabriz University of Medical, Tabriz, 5166614766, Iran.ORCID 0000-0003-4883-9924
Matthes ZessinDepartment of Enzymology, Institute of Biochemistry, Martin-Luther-University Halle-Wittenberg, Halle/Saale, 06120, Germany.
Mike SchutkowskiDepartment of Enzymology, Institute of Biochemistry, Martin-Luther-University Halle-Wittenberg, Halle/Saale, 06120, Germany.ORCID 0000-0003-0919-7076
Wolfgang SipplDepartment of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle/Saale, 06120, Germany.ORCID 0000-0002-5985-9261
Siavoush DastmalchiBiotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, 5165665813, Iran.ORCID 0000-0001-9427-0770
Tabriz University of Medical Sciences · IRMartin Luther University Halle-Wittenberg · DEQom University of Medical Science and Health Services · IR
Funding
Biotechnology Research Center, Tabriz University of Medical Sciences 60360Research Office and Biotechnology Research Center of Tabriz University of Medical Sciences 60360
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation. · full record | OpenQuestion